FLUI — Fluicell AB Share News
0.000.00%
Last trade - 00:00- SEK53.30m
- SEK52.00m
- SEK6.00m
Brief: Fluicell To Launch Biozone 6 In Q1 2021
Brief: Fluicell Gets Order From Slovakia
Brief: Fluicell AB - Q3 Operating Loss Sek 5.2 Million
Brief: Fluicell Gets EUR 0.5 Mln Grant From EU's Horizon 2020
Brief: Fluicell Carries Out New Directed Issue Of About SEK 4 Mln
Brief: Fluicell Receives Order For BioPen System
Brief: Fluicell Signs Distribution Deal With Swift Analytical
Brief: Fluicell Signs Distribution Deal With Swift Analytical
Brief: Fluicell Q2 Operating Loss Narrows To SEK 3.3 Mln
Brief: Fluicell Gets Additional Order For EUR 13,500
Brief: Fluicell Raises SEK 26.6 Mln Through Excercise Of Warrants
Brief: Fluicell Gets Purchase Order From Oblique Therapeutics
Brief: Fluicell Gets Warning Letter Where Party Submits Claims For Patent Infringement
Brief: Fluicell Enters New Distribution Agreement With AXT Pty Ltd
Brief: Fluicell Q1 EBITDA Narrows To Loss SEK 3.6 Million
Brief: Fluicell Renews Deal With Gedeon Richter
Brief: Fluicell Gets Order From Oblique Therapeutics
Brief: Fluicell Still Expects To Achieve Positive Cashflow And Break-Even Around Mid-2022
Brief: Fluicell Gets Order Worth EUR 61,000